Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lindsey C. Beaulieu"'
Autor:
Peiyao Cheng, Craig Kollman, Fida Bacha, Georgeanna J. Klingensmith, Risa M. Wolf, Lindsey C. Beaulieu, Anne L. Adolph, William V. Tamborlane, Robin L. Gal, Ashley H. Shoemaker
Publikováno v:
Diabetes care.
OBJECTIVE Type 2 diabetes in the U.S. is more prevalent in youth of minority racial-ethnic background, but disparities in health outcomes have not been examined in this population. RESEARCH DESIGN AND METHODS We examined racial-ethnic differences in
Autor:
Elvira Isganaitis, Georgeanna J. Klingensmith, Lindsey C. Beaulieu, Michelle A. Van Name, Lucy D. Mastrandrea, William V. Tamborlane, Sheela N. Magge, Craig Kollman, Robin L. Gal, Peiyao Cheng, Risa M. Wolf
Publikováno v:
Diabetes. 69
Background: Given the paucity of treatment options for youth with type 2 diabetes (T2D), insulin is commonly used to rapidly reverse gluco-toxicity. Subsequently, some youth with short duration T2D can be weaned off insulin soon after diagnosis. We a
Autor:
Mark A. Clements, Anna Mazzuoccolo, Peter Calhoun, Jennifer L. Sherr, Roy W. Beck, Susana R. Patton, Zhaomian Li, Lindsey C. Beaulieu, Michael C. Riddell, Ellis Greene, Robin L. Gal
Publikováno v:
Diabetes. 69
Understanding glucodynamics in youth with T1D during a variety of physical activities (PA) may help guide management customized to type of activity. The present study profiled PA, heart rate (HR) and glycemia in youth participating in 5-day hockey ca
Autor:
Elvira Isganaitis, Craig Kollman, William V. Tamborlane, Peiyao Cheng, Lindsey C. Beaulieu, Michelle A. Van Name, Robin L. Gal, Georgeanna J. Klingensmith, Lucy D. Mastrandrea
Publikováno v:
Diabetes. 68
Background: While consensus guidelines indicate that all youth with T2D should be treated with metformin ± insulin at diagnosis, >10% of patients were treated solely with diet/lifestyle on enrollment in the Pediatric Diabetes Consortium (PDC) T2D Re
Autor:
Peiyao Cheng, Ashley H. Shoemaker, Fida Bacha, Lindsey C. Beaulieu, Robin L. Gal, Georgeanna J. Klingensmith, Ishita Jindal, Craig Kollman, Risa M. Wolf, Anne L. Adolph, William V. Tamborlane
Publikováno v:
Diabetes. 68
Background: Racial differences in diabetes control and cardiovascular disease risk factors have been reported in youth with diabetes, with minority youth having worse glycemic control and comorbidities compared with non-Hispanic white (NHW) peers. Me
Autor:
Lisa M. Looper, Robin L. Gal, Ramon L. Adams, Peiyao Cheng, Craig Kollman, Georgeanna J. Klingensmith, Lindsey C. Beaulieu, Tamara S. Hannon, William V. Tamborlane
Publikováno v:
Diabetes. 68
Background: Youth with T2D experience barriers to obtaining diabetes care. We evaluated whether healthcare utilization (HCU) was associated with glycemic outcomes in youth with T2D. Methods: We evaluated annual HCU in 1,324 T2D PDC youth by diabetes
Autor:
Rachel C. Edelen, Amanda M. Terry, Laura B. Smith, Robin L. Gal, Ashby F. Walker, Sureka Bollepalli, Lindsey C. Beaulieu, Joane E. Less
Publikováno v:
Diabetes. 67
Background: While behavior and diet modifications are the first line of defense in treating T2D, pediatric patients requiring additional intervention have few options compared with adults with T2D. The disparity in available treatments can be attribu
Autor:
Georgeanna J. Klingensmith, Kupper A. Wintergerst, Joane E. Less, Lindsey C. Beaulieu, Kimberly D. Keelin, Bryce A. Nelson, Robin L. Gal, William V. Tamborlane
Publikováno v:
Diabetes. 67
Background: Treatment options for youth with type 2 diabetes (T2D) are limited compared to those for adults with T2D. As pediatric clinical trials in T2D are difficult to complete, due to lower prevalence and population related recruitment challenges
Autor:
GEORGEANNA J. KLINGENSMITH, PEIYAO CHENG, ROBIN L. GAL, LINDSEY C. BEAULIEU, WILLIAM V. TAMBORLANE, FIDA BACHA, MEGAN M. KELSEY, CRAIG KOLLMAN, PEDIATRIC DIABETES CONSORTIUM
Publikováno v:
Diabetes. 67
Objective: To describe the characteristics of youth diagnosed with T2D who have tested positive for ≥1 islet autoantibody (IA) and to examine the persistence of IA over time. Methods: Youth enrolled in the PDC T2D Registry with ≥2 years follow-up
Autor:
Lori M. Laffel, Michelle Katz, Robin L. Gal, Nidhi Bansal, Michelle A. Van Name, Craig Kollman, William V. Tamborlane, Lindsey C. Beaulieu, Peiyao Cheng
Publikováno v:
Diabetes. 67
Introduction: Youth with T2D are at risk for additional cardiovascular (CVD) diseases such as hypertension (HT) and hyperlipidemia (HLD). We examined healthcare provider (HCP) self-reported practices regarding management and treatment of HT and HLD i